Portfolio

Our partners are powering a new era of AI-driven bioacceleration. They’re building the engineering, data science, machine learning, automation, software tooling, and computation needed for quantum leaps in science and medicine.

Abridge

*

Enterprise generative AI for clinical conversations.

Axiom

*

Eliminating molecular toxicity by replacing experiments with AI.

Evolv

*

Developing natural products for pharmaceutical grade efficacy.

HoX

*

Vertical integrated genomics computing. 

Lighten

*

Unstructured data abstraction for modern medicine. 

Molecule

*

Decentralized protocol for early stage biology discovery and funding.

Peer

*

Rewriting regulated biopharma workflows.

Photon

*

The modern patient-first pharmacy infrastructure.

ReSync

*

Single source of truth for scientific workflows.

ReachRX

*

Data science platform for speciality pharma. 

Sensible Bio

*

In vivo mRNA biomanufacturing.

Sleuth

*

Agentic business intelligence for biopharma.

Specie Bio

*

Biospecimine data exchange for clinical research.

Tandem

*

Automated market access for speciality pharma patients and clinicians. 

Trially

*

Integrated clinical trial automation for sponsors and sites.

Velocity Bio

*

Targeting underdrugged enzymatic diseases.

*Extended Atria portfolio companies (SPV investments prior to Fund I)